BeRNA Therapeutics
Our mission is to relieve chronic neuropathic pain quickly, safely and effectively by combining miRNA therapeutics with nerve stimulation.
- Stage Full Product Ready
- Industry Biotechnology
- Location Boston, MA, US
- Currency USD
- Founded May 2014
- Employees 3
- Website bernatherapeutics.com
Company Summary
BeRNA Therapeutics is developing an innovative and very effective use of biological drugs to alleviate chronic pain. BeRNA has identified drug candidates and developed a method of delivering them locally using a proprietary delivery device, which combines microneedles and electrical stimulation of the target area of a patient's body. Patients benefit from an innocuous non-invasive delivery and short delay between targeted delivery and relief.
Team
-
Owner, Founder and Chief Executive OfficerScientist with over 15 years of experience leading laboratory work investigating chronic and untreatable diseases at Biogen Idec, Harvard Medical School, University College Dublin and University of Pisa.
Molecular and cellular biologist with experience in biologics drug discovery.
Advisors
-
Michael ReiterFinancial advisor and strategy consultant.Unconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.